Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 196–210 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4882 PECAM1 Gene Immunological Disorder Genetic Test This test evaluates the PECAM1 gene for pathogenic variants associated with immunological, dermatological, and osteological disorders.	Peripheral whole blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PECAM1 gene", "Full gene sequencing coverage"] Parameters [] Preparation ["Pre-test genetic counseling is mandatory", "Do not discontinue prescribed medications without consultation"] Indications ["Suspected PECAM1-related immunological disorders", "Dermatological conditions linked to PECAM1", "Osteological disorders potentially caused by PECAM1 variants"] Measurement technique Confirm with laboratory Codes LOINC: 48004-7 ICD-10: D84.9 Clinical summary This test evaluates the PECAM1 gene for pathogenic variants associated with immunological, dermatological, and osteological disorders.
TEST-5174 PET100 Gene Mitochondrial Complex IV Deficiency Genetic Test This test identifies pathogenic variants in the PET100 gene, which are associated with mitochondrial complex IV deficiency.	Peripheral Whole Blood (EDTA), Buccal Swab, or FTA Card	3–4 Weeks (21–28 Calendar Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PET100 gene", "Mitochondrial complex IV assembly and function"] Parameters [] Preparation ["No special dietary or medication restrictions are required prior to collection.", "Genetic counseling is strongly recommended prior to testing."] Indications ["Unexplained neurological regression", "Suspected Leigh syndrome", "Familial mitochondrial disease", "Abnormal metabolic screening suggestive of respiratory chain dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 21635-9 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the PET100 gene, which are associated with mitochondrial complex IV deficiency.
TEST-5969 PEX12 Gene Zellweger Syndrome Genetic Test This test analyzes the PEX12 gene for pathogenic variants associated with Zellweger syndrome.	Whole blood (EDTA) or dried blood spot	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PEX12 gene coding region", "Pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions"] Indications ["Clinical suspicion of Zellweger syndrome", "Carrier screening in families with a history of peroxisomal disorders"] Measurement technique Confirm with laboratory Codes LOINC: 98228-7 ICD-10: E71.510 Clinical summary This test analyzes the PEX12 gene for pathogenic variants associated with Zellweger syndrome.
TEST-4877 PGAP1 Gene Autosomal Recessive Intellectual Disability Type 42 (MRT42) Genetic Test This test detects pathogenic variants in the PGAP1 gene associated with autosomal recessive intellectual disability type 42 (MRT42).	Peripheral Whole Blood	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PGAP1 gene", "Single-Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)"] Parameters [] Preparation ["Fasting is not required.", "Inform phlebotomist of all current medications and supplements, especially anticoagulants, antiplatelet agents, and high-dose omega-3 fatty acids."] Indications ["Clinical suspicion of Autosomal Recessive Intellectual Disability Type 42 (MRT42)", "Family history of MRT42", "Confirmation of clinical diagnosis", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: F78, Z15.89, Z13.8 Clinical summary This test detects pathogenic variants in the PGAP1 gene associated with autosomal recessive intellectual disability type 42 (MRT42).
TEST-2723 PGAP2 Gene NGS Test for HPMRS3 This diagnostic test evaluates the PGAP2 gene for pathogenic variants associated with Hyperphosphatasia with Mental Retardation Syndrome Type 3 (HPMRS3).	Whole blood (EDTA) or Dried Blood Spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PGAP2 gene", "Copy Number Variations (CNV) in the PGAP2 gene"] Parameters [{"name": "Variant Resolution", "reference_range": "Full gene coding region ±10 bp, CNV detection"}, {"name": "Analytical Sensitivity", "reference_range": "99.9%"}] Preparation ["No specific fasting required.", "Inform lab of any recent blood transfusions (within 4 weeks)."] Indications ["Clinical suspicion of HPMRS3", "Family history of HPMRS3", "Need for genetic counseling and recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 82125-8 ICD-10: Q87.8 Clinical summary This diagnostic test evaluates the PGAP2 gene for pathogenic variants associated with Hyperphosphatasia with Mental Retardation Syndrome Type 3 (HPMRS3).
TEST-4972 PHF8 Gene Sequencing (Siderius Syndrome) Test This test analyzes the PHF8 gene to identify variants associated with X-linked intellectual disability Siderius type.	Whole Blood (Peripheral Venous)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PHF8 gene coding region", "PHF8 gene splice sites"] Parameters [] Preparation ["Genetic counselling session mandatory before testing", "No special preparation required for blood draw"] Indications ["Suspected X-linked intellectual disability Siderius type", "Family planning for carrier status"] Measurement technique Confirm with laboratory Codes LOINC: 81661-6 ICD-10: Z13.71, F78.9, Z82.79 Clinical summary This test analyzes the PHF8 gene to identify variants associated with X-linked intellectual disability Siderius type.
TEST-6330 PHKA2 Gene (Glycogen Storage Disease Type IXa) Genetic Test This genetic test identifies pathogenic variants in the PHKA2 gene associated with Glycogen Storage Disease Type IXa.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PHKA2 gene", "SNVs, indels, CNVs"] Parameters [] Preparation ["Genetic counselling session recommended before sample submission"] Indications ["Clinical suspicion of Glycogen Storage Disease Type IXa", "Family history of GSD IXa", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 74046-9 ICD-10: E74.09 Clinical summary This genetic test identifies pathogenic variants in the PHKA2 gene associated with Glycogen Storage Disease Type IXa.
TEST-5102 PHOX2A Gene Congenital Fibrosis of Extraocular Muscles Type 2 Genetic Test This test identifies pathogenic variants within the PHOX2A gene associated with Congenital Fibrosis of Extraocular Muscles Type 2 (CFEOM2). It is performed using Next-Generation Se...	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 Weeks (21–28 business days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PHOX2A gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)"] Parameters [{"name": "PHOX2A Gene Sequencing", "reference_range": "No pathogenic variants detected"}] Preparation ["No specific fasting required", "Inform lab of any medications being taken"] Indications ["Suspected diagnosis of Congenital Fibrosis of Extraocular Muscles Type 2 (CFEOM2)", "Family history of CFEOM2", "Genetic counselling for families with CFEOM2"] Measurement technique Confirm with laboratory Codes LOINC: 21600-1 ICD-10: H49.81 Clinical summary This test identifies pathogenic variants within the PHOX2A gene associated with Congenital Fibrosis of Extraocular Muscles Type 2 (CFEOM2). It is performed using Next-Generation Sequencing (NGS) on a blood or DNA sample.
TEST-5369 PIEZO2 Gene Distal Arthrogryposis Type 5 (DA5) Genetic Test This genetic test identifies pathogenic mutations in the PIEZO2 gene associated with Distal Arthrogryposis Type 5 (DA5). It uses next-generation sequencing to provide comprehensive...	Whole Blood (EDTA or lithium heparin), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the PIEZO2 gene", "Full gene coverage (exons + intron boundaries)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions (within 2 weeks)"] Indications ["Suspected Distal Arthrogryposis Type 5 (DA5)", "Presence of congenital contractures, cleft palate, or aberrant papillary ridges", "Family history suggestive of DA5"] Measurement technique Confirm with laboratory Codes LOINC: 78843-0 ICD-10: Q74.3 Clinical summary This genetic test identifies pathogenic mutations in the PIEZO2 gene associated with Distal Arthrogryposis Type 5 (DA5). It uses next-generation sequencing to provide comprehensive gene coverage.
TEST-2956 PITX1 Gene Clubfoot Genetic Test This test identifies genetic variants in the PITX1 gene associated with clubfoot.	Blood (EDTA), DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PITX1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation [] Indications ["Diagnosis of isolated or syndromic clubfoot", "Genetic counselling for families with clubfoot", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 92917-4 ICD-10: Q66.0, Q66.89, Z15.89 Clinical summary This test identifies genetic variants in the PITX1 gene associated with clubfoot.
TEST-5214 PKP1 Gene Ectodermal Dysplasia-Skin Fragility Syndrome Genetic Test This genetic test identifies pathogenic variants in the PKP1 gene associated with ectodermal dysplasia-skin fragility syndrome.	Peripheral whole blood (EDTA) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PKP1 gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Clinical suspicion of EDSFS", "Inconclusive histopathology", "Family history of EDSFS"] Measurement technique Confirm with laboratory Codes LOINC: 76978-4 ICD-10: Q82.8 Clinical summary This genetic test identifies pathogenic variants in the PKP1 gene associated with ectodermal dysplasia-skin fragility syndrome.
TEST-5720 PLEKHG5 Gene Distal Spinal Muscular Atrophy Type 4 (DSMA4) Genetic Test This genetic test identifies pathogenic mutations in the PLEKHG5 gene associated with distal spinal muscular atrophy type 4 (DSMA4).	Whole Blood (EDTA tube), Extracted DNA, or FTA Card Spot	3 – 4 weeks (21 – 28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PLEKHG5 gene mutations", "Pathogenic variants in coding exons and splice sites"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected diagnosis of Distal Spinal Muscular Atrophy Type 4 (DSMA4)", "Family history of DSMA4", "Carrier screening in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 21665-1 ICD-10: G12.21 Clinical summary This genetic test identifies pathogenic mutations in the PLEKHG5 gene associated with distal spinal muscular atrophy type 4 (DSMA4).
TEST-3838 PNKP Gene Ataxia-Oculomotor Apraxia Type 4 Genetic Test This genetic test identifies pathogenic variants in the PNKP gene associated with Ataxia-Oculomotor Apraxia Type 4 (AOA4). It analyzes the entire coding region and splice sites usi...	Venous Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PNKP gene", "Copy Number Variations (CNV) in the PNKP gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of Ataxia-Oculomotor Apraxia Type 4 (AOA4)", "Family history of AOA4", "Carrier screening in families with AOA4"] Measurement technique Confirm with laboratory Codes LOINC: 81405-9 ICD-10: G11.3 Clinical summary This genetic test identifies pathogenic variants in the PNKP gene associated with Ataxia-Oculomotor Apraxia Type 4 (AOA4). It analyzes the entire coding region and splice sites using Next Generation Sequencing.
TEST-5180 POMT1 Gene Muscular Dystrophy-Dystroglycanopathy (Congenital with Intellectual Disability), Type B1 Test This test identifies pathogenic variants in the POMT1 gene associated with congenital muscular dystrophy-dystroglycanopathy type B1.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["POMT1 gene coding region", "Intron-exon boundaries"] Parameters [] Preparation ["No fasting required", "No medication adjustments required"] Indications ["Infants and children with floppy baby syndrome", "Global developmental delay", "Elevated serum creatine kinase (CK)", "Neuroradiological findings consistent with cobblestone lissencephaly or pontocerebellar hypoplasia"] Measurement technique Confirm with laboratory Codes LOINC: 94225-7 ICD-10: G71.2, Q04.8, Z84.81 Clinical summary This test identifies pathogenic variants in the POMT1 gene associated with congenital muscular dystrophy-dystroglycanopathy type B1.
TEST-3574 PPARG Gene Test This test evaluates the PPARG gene for pathogenic variants associated with severe monogenic obesity.	Whole Blood or FTA Card Specimen	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PPARG gene", "Coding region variants", "Intron-exon boundaries"] Parameters [] Preparation ["No fasting or special preparation is required."] Indications ["Patients with BMI > 40 kg/m² before age 30", "Strong family history of severe obesity", "Clinical suspicion of monogenic obesity syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 59079-3 ICD-10: E66.8 Clinical summary This test evaluates the PPARG gene for pathogenic variants associated with severe monogenic obesity.

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you need—schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.